Metastatic components in colorectal cancer

被引：7

作者：

Javarsiani, Marjan Hajimoradi ^{[1
]}

Javanmard, Shagayegh Haghjooy ^{[2
]}

Colonna, Francesca ^{[3
]}

机构：

[1] Shiraz Univ, Sch Vet Med, Dept Basic Sci, Shiraz, Iran

[2] Isfahan Univ Med Sci, Appl Physiol Res Ctr, Cardiovasc Res Inst, Esfahan, Iran

[3] Cattolica Sacro Cuore Largo Francesco Univ, Dept Gen Pathol, Rome, Italy

来源：

JOURNAL OF RESEARCH IN MEDICAL SCIENCES | 2019年 / 24卷

关键词：

Cancer stem cells; colorectal cancer; metastasis; tumor microenvironment; GROWTH-FACTOR RECEPTOR; STROMAL FIBROBLASTS; TUMOR ANGIOGENESIS; STEM-CELLS; EXPRESSION; HETEROGENEITY; ACTIVATION; MODEL; SMAD4;

D O I：

10.4103/jrms.JRMS_957_18

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Recent experiments have shown that cells with different genetic mutations can give rise to cancer transformation, both in vitro and in vivo, supported by the crosstalk between cancer cells and stroma. The stroma and the complex set of involved cells make up the tumor microenvironment that supports the engraftment of metastatic cells. In fact, environmental factors support colorectal cancer arise by formation and maintenance of cancer stem cells (CSCs). In this review, we discuss interactions between CSCs and their microenvironment that can provide better therapeutic opportunities in the metastatic cancer.

引用

页数：7

共 50 条

[1] The metabolic syndrome and its components as prognostic factors in metastatic colorectal cancer
Reed, Melissa
Patrick, Caitlyn
Croft, Brianna
Walde, Natalie
Voutsadakis, Ioannis A.
INDIAN JOURNAL OF GASTROENTEROLOGY, 2019, 38 (01) : 15 - 22
[2] The metabolic syndrome and its components as prognostic factors in metastatic colorectal cancer
Melissa Reed
Caitlyn Patrick
Brianna Croft
Natalie Walde
Ioannis A. Voutsadakis
Indian Journal of Gastroenterology, 2019, 38 : 15 - 22
[3] Metastatic colorectal cancer
Bouche, Olivier
Conroy, Thierry
Michel, Pierre
Penna, Christophe
Tournigand, Christophe
GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2006, 30 : S30 - S42
[4] Metastatic colorectal cancer
Kindler H.L.
Shulman K.L.
Current Treatment Options in Oncology, 2001, 2 (6) : 459 - 471
[5] Metastatic colorectal cancer
Saletti, Piercarto
Cavalli, Franco
CANCER TREATMENT REVIEWS, 2006, 32 (07) : 557 - 571
[6] Metastatic colorectal cancer
Horgan, Paul G.
SURGICAL ONCOLOGY-OXFORD, 2007, 16 (01): : 1 - 1
[7] Metastatic Colorectal Cancer
Passardi, Alessandro
Marisi, Giorgia
Ulivi, Paola
CANCERS, 2021, 13 (24)
[8] Negative Effects of Transfused Blood Components after Hepatectomy for Metastatic Colorectal Cancer
Cannon, Robert M.
Brown, Russell E.
Hill, Charles R. St.
Dunki-Jacobs, Eric
Martin, Robert C. G., II
McMasters, Kelly M.
Scoggins, Charles R.
AMERICAN SURGEON, 2013, 79 (01) : 35 - 39
[9] Kras in metastatic colorectal cancer
Wicki, Andreas
Herrmann, Richard
Christofori, Gerhard
SWISS MEDICAL WEEKLY, 2010, 140 : 14 - 19
[10] Panitumumab in metastatic colorectal cancer
Hocking, Christopher M.
Townsend, Amanda R.
Price, Timothy J.
EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (07) : 781 - 793

← 1 2 3 4 5 →